CD8+ T cells can aggravate tissue damage, which may sustain a tumor‐promoting chronic inflammation (Monteleone et al., 2012), but they also release different cytotoxic molecules such as IFN‐γ which kill dysplastic cells (Restifo et al., 2012). This evidence concerns the gene CD8A and neoplasm.